Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

摘要

Methods are disclosed utilizing the optically pure (+) isomer of doxazosin. This compound is a potent drug for the treatment of benign prostatic hyperplasia while avoiding the concomitant liability of hypotensive effects associated with the racemic mixture of doxazosin.